IntroductionRetained radioactivity of 131I after ablation therapy largely differs in each patient according to factors including the amount of remnant thyroid tissue, renal function, and use of recombinant human thyroid-stimulating hormone. To reduce unnecessary restriction of patient's daily life after inpatient 131I ablation therapy, we propose a practical individualized method for radiation precaution based on dose rate at release time.MethodsWe evaluated 215 patients with differentiated thyroid cancer who underwent inpatient 131I ablation therapy following total thyroidectomy. Effective dose equivalent rates at 1-m distance were measured upon release (EDRR) on day 2 and during delayed whole-body scan (EDRD) visits on day 6‒8 after 131I ...
Radioactive iodine is utilized commonly for ablation of remnant thyroid tissue after thyroidectomy a...
Radioactive iodine is commonly administered following thyroidectomy for differentiated thyroid carci...
Radioiodine treatments of patients with well-differentiated thyroid carcinoma have generally been sa...
Patients treated with radioiodine present a radiation hazard and precautions are necessary to limit ...
Radiation safety is an integral part of targeted radionuclide therapy. The aim of this work was to s...
Radioiodine (131I iodide) has long been a safe, effective and widely used treatment in the managemen...
Absorbed doses to family members of patients treated with (131)I were measured using thermoluminesce...
Purpose: Effective half life of I-131 (Teff) in patients with differentiated thyroid cancer treated ...
The aim of this study was to measure the radiation exposure rate from differentiated thyroid carcino...
Hyperthyroid patients treated with radioiodine (I-131) pose an external radiation risk to individual...
Empirical equations were proposed for the prediction of the ambient dose equivalent rates from patie...
Radioiodine therapy of hyperthyroidism is the most frequently performed radiopharmaceutical therapy....
Due to the remarkable increase in thyroid cancer cases, the number of patients treated with radioiod...
Radioactive iodine 131I has been used for many years to treat benign thyroid disease. Treatment of t...
Purposes: To evaluate the dosimetric effect of outpatient radioiodine therapy for thyroid cancer in ...
Radioactive iodine is utilized commonly for ablation of remnant thyroid tissue after thyroidectomy a...
Radioactive iodine is commonly administered following thyroidectomy for differentiated thyroid carci...
Radioiodine treatments of patients with well-differentiated thyroid carcinoma have generally been sa...
Patients treated with radioiodine present a radiation hazard and precautions are necessary to limit ...
Radiation safety is an integral part of targeted radionuclide therapy. The aim of this work was to s...
Radioiodine (131I iodide) has long been a safe, effective and widely used treatment in the managemen...
Absorbed doses to family members of patients treated with (131)I were measured using thermoluminesce...
Purpose: Effective half life of I-131 (Teff) in patients with differentiated thyroid cancer treated ...
The aim of this study was to measure the radiation exposure rate from differentiated thyroid carcino...
Hyperthyroid patients treated with radioiodine (I-131) pose an external radiation risk to individual...
Empirical equations were proposed for the prediction of the ambient dose equivalent rates from patie...
Radioiodine therapy of hyperthyroidism is the most frequently performed radiopharmaceutical therapy....
Due to the remarkable increase in thyroid cancer cases, the number of patients treated with radioiod...
Radioactive iodine 131I has been used for many years to treat benign thyroid disease. Treatment of t...
Purposes: To evaluate the dosimetric effect of outpatient radioiodine therapy for thyroid cancer in ...
Radioactive iodine is utilized commonly for ablation of remnant thyroid tissue after thyroidectomy a...
Radioactive iodine is commonly administered following thyroidectomy for differentiated thyroid carci...
Radioiodine treatments of patients with well-differentiated thyroid carcinoma have generally been sa...